Sunday 22 June
14.00-15.00
Registration
15:00-15.45
Industry sponsored Symposium
Chair: Bernd Merkl, Troels Lillebaek
​
15:00 Inna Friesen, Borstel, Germany
Redefining the diagnosis of drug-resistant TB: Clinical validation of FluoroType® MTBDR VER2.0 and first results of tNGS workflow integration.
15.45-16.15
Coffee Break​​​
16.15-16.45
Selected flash talks (5 min)
Chairs:
​​​
16:45-19.00
Opening session
Chair: Troels Lillebaek, Miguel Viveiros, Raquel Duarte
16:45
Welcome words, ESM and congress Presidents
​
Opening Keynote
17:00 Raquel Duarte, University of Porto
GL01 Challenges in Tuberculosis Management Today
​​​​
17:45
Gertrud Meissner Award presented by S. Niemann​​​
​
18:10
GL02 Gardner Middlebrook Award
19.00-21.30
Networking drinks and light dinner snacks at the INSTITUTE OF HYGIENE AND TROPICAL MEDICINE
Monday 23 June
08:00-08:30
Registration
08:30-10:00
Session 1: Molecular Biology and Mycobacterial Evolution
The evolutionary history and phylogeny of mycobacteria, along with genomics for tracking transmission, resistance, and the evolution of drug resistance mechanisms provide comprehensive insights into their biology and adaptation.
Chair: Christophe Sola, João Perdigão
08:30 Roland Brosch, Institut Pasteur, Paris
GL03 The Evolutionary History and Phylogeny of Mycobacteria
4 oral presentations
​
10:00-10:30
Coffee Break
10:30-12:00
Session 2: One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
The impact of aging, chronic diseases, co-infections, climate change, water quality, and microbiota on M. tuberculosis and non-tuberculous mycobacterial infections, as well as zoonotic tuberculosis in the One Health Era, highlights the need for an integrated approach addressing human, animal, and environmental health to prevent mycobacterial infection and transmission
Chair: Nuno Empadinhas, Leen Rigouts
11:00 Jean-François Guégan, UMR MIVEGEC, Montpellier, France
GL04 Canonical fact versus hypothesis testing to decipher transmission of non-tuberculous and tuberculous mycobacteria
4 oral presentations
12:00-12:25
Poster pitches - Session 1
Chair:
1 minute per poster (25 posters)
12:25-13:25
Lunch
13:25-14:30
Poster Session 1
14:30-16:00
Session 3: Host-Pathogen interactions in TB
Advances in understanding the immune response to M. tuberculosis infection, including lineage-specific drivers of differential immune response and virulence, have highlighted biomarkers of protection and susceptibility as well as potential host-directed therapies.
​
Chair: Iñaki Comas, Margarida Saraiva
14:30 Mireia Coscolla, University of Valencia
GL05 Evolutionary insights in host-pathogen compatibility of M. tuberculosisecotypes.
4 oral presentations
16:00-16:30
Coffee Break
16:30-18:00
Session 4: Clinical pathology and diagnostic advances
Diagnostic advances, artificial intelligence and new technologies relevant to clinical pathologists and laboratory professionals.
Chair: Daniela Cirillo, Rita Macedo
16:30 Daniel Maria Cirillo, San Raffaele Hospital, Milan
GL06 Co-development of new drugs and diagnostics to prevent drug resistance emergence
​
4 selected abstracts​​​
18:30
Transfer to central Lisboa, guided tour and traditional dinner
Tuesday 24 June
08:00-08:30
Registration
08:30-10:00
Session 5: Recent advances in research on Mycobacterial pathogenesis
Experimental infection models, ranging from vertebrates, rodents, and non-human primates to novel in vitro systems such as human granulomas, organoids, and lung-on-a-chip.
Chair: Mireia Coscolla, Maria Salomé Gomes
08:30 William Branchett, Francis Crick Institute, London​
GL07 Models and Mechanisms of M. tuberculosis Infection Outcome
​
4 selected abstracts
​​
10:00-10:30
Poster pitches - Session 2
Chair:
​
1 minute per poster (25 posters)
10:30-11:00
Coffee Break
11:00-12:30
Session 6: New generation vaccines for TB
Advances in vaccine research, including innovative adjuvants and strategies tailored to different epidemiological profiles driving the development of next-generation tuberculosis vaccines
​
Chair: Matthias Merker, Elsa Anes
​
11:00 Helen McShane, University of Oxford
GL08 Progress and challenges in tuberculosis vaccine development.​
​
4 selected abstracts
​​
12:30-13:00
Poster pitches - Session 3
Chair:
​
1 minute per poster
13:00-14:00
Lunch
14:00-15:00
Poster Session 2
15:00-15:45
Industry sponsored Symposium
​Chairs:
15:00 TBC
TBC​​
15:45 - 16:15
Session 7: Therapeutic strategies for NTM
Treatment of NTM focused on evidence for new drugs, including antibiotic and non-antibiotic combinations, alongside discontinuation strategies and treatment adjustments based on clinical response.
​
Chair: Troels Lillebaek, Raquel Duarte
15:45 Natalie Lorent, KU Leuven
​GL09 Rethinking NTM management: new drugs, new approaches, new hope.
16:15-16:45
Coffee Break
16:45-18:30
Session 8: Therapeutic strategies for TB and NTM Part 2
Chair: Daniela Maria Cirillo, Raquel Duarte
​​​
7 Selected abstracts
18:30
General Assembly
19:30
Social activity: Dinner and party
Wednesday 25 June
08.30-09:00
Registration
09.00-10.30
Session 9: Neglected mycobacterial diseases - Continuing challenges for a hopeful futur
New hurdles in the fight against neglected mycobacterial diseases such as leprosy and Buruli - resistance, challenges in diagnosis, and the debate between molecular and traditional methods to better identify these often non-cultivable pathogens.
​
Chair: Margarida Correia-Neves, Leen Rigouts
​
09:00 Leen Rigouts, Institute of Tropical Medicine, Antwerp
GL10 Neglected mycobacterial diseases - Continuing challenges for a hopeful future
09:30 Emmanuelle Cambau, APHP-GHU Nord & Université Paris Cité
GL11 Leprosy: back to the future
​2 selected abstracts
10.30-11:00
Coffee Break
11:00-12.30
Session 10: Systems Biology Approaches to Accelerate Mycobacteriosis Drug Discovery
Emerging areas in the fight against TB and NTM including omics approaches for identifying new host and pathogen drug targets, advancements in drug delivery methods, drug discovery and repurposing pipelines for mycobacteriosis, exploration of non-antibiotic treatments, and innovations in adaptive clinical trial designs.​
​
Chair: Miguel Viveiros, Troels Lillebaek
​
11:00 Hannu Myllykallio, Polytechnique; Palaiseau
GL12 From Abyss to Mycobacterial Drug Discovery
​​
4 selected abstracts
​​
12:30-13.00
Poster Awards and Closing Ceremony
Chair: Troels Lillebaek, Leen Rigouts